| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 Oxford University Press
CORRESPONDENCE |
Re: The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence
Affiliation of author: Centre for Epidemiology and Biostatistics, University of Leeds, Arthington House, Cookridge Hospital, Hospital Lane, Leeds, UK
Correspondence to: David Forman, PhD, Professor of Cancer Epidemiology, University of Leeds, Centre for Epidemiology and Biostatistics, Arthington House, Cookridge Hospital, Hospital Lane, Leeds, LS16 6QB, UK (e-mail: d.forman@leeds.ac.uk).
| The first 10% of the full text of this article appears below. |
Pohl and Welch consider whether the reported dramatic increase in esophageal adenocarcinoma represents a real increase in disease burden or whether it can be explained by artifacts introduced by classification problems and/or increased diagnostic intensity (1). Based on an analysis of the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) database, they conclude that the observed increase not only represents a true increase in
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2005 97: 1014.